Insulet names ex-IDEXX CEO Jay Mazelsky to board, effective July 1, 2026

IDEXX Laboratories, Inc.
Insulet Corporation

IDEXX Laboratories, Inc.

IDXX

0.00

Insulet Corporation

PODD

0.00
  • Insulet named Jonathan “Jay” Mazelsky to its board as an independent director, effective July 1, 2026.
  • Mazelsky is executive chair at IDEXX Laboratories.
  • He served as IDEXX president and CEO from October 2019 to May 2026.
  • Earlier roles included senior vice president and general manager at Philips Healthcare.
  • He also sits on the board of Dentsply Sirona.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insulet Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20260625109124) on June 25, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.